FirsthandHealth
medRxiv PreprintsInternational2 October 2026

Improving MASLD Identification in Patients with T2D: A Computable Phenotype Framework Integrating Structured Data and Clinical Notes

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with type 2 diabetes (T2D), yet accurate identification from electronic health records (EHRs) remains challenging because clinically relevant information is fragmented across structured data and unstructured clinical documentation. We developed a rule-based computable phenotype (CP) framework that integrates structured EHRs with clinical notes for scalable MASLD identification in patients with T2D. The framework comprises five complementary CP algorithms derived from validated fibrosis indice
— medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.